Brimonidine ophthalmic and Factor VIIa (Recombinant)
Determining the interaction of Brimonidine ophthalmic and Factor VIIa (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine (Ophthalmic)
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine ophthalmic-Factor X (Human)
- Brimonidine ophthalmic-Factor x human Intravenous
- Brimonidine ophthalmic-Factor XIII
- Brimonidine ophthalmic-Factor XIII (Human)
- Brimonidine ophthalmic-Factor XIII A-Subunit (Recombinant)
- Brimonidine ophthalmic-Factor XIII Concentrate (Human)
- Factor VIIa (Recombinant)-Brimonidine Tartrate eent
- Factor VIIa (Recombinant)-Brimonidine Tartrate topical
- Factor VIIa (Recombinant)-Brimonidine topical
- Factor VIIa (Recombinant)-Brimonidine Topical application
- Factor VIIa (Recombinant)-Brintellix
- Factor VIIa (Recombinant)-Brinzolamide